跳至主要内容
临床试验/NCT02243514
NCT02243514Unknown不适用

Intravascular Ultrasound Evaluation of the Renal Nerves Remodeling in Different Diseases

The Second Affiliated Hospital of Chongqing Medical University1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2014年10月最近更新:
适应症

试验速览

阶段
不适用
入组人数
60
试验地点
1
主要终点
Area increase of Renal nerves in patients with sympathetic over-activity diseases

研究概览

简要总结

Sympathetic hyperactivity is a causal or a promoting factor in many diseases, under these conditions, some morphology changes due to the hyperactivity occur. Renal nerve is an important part in the autonomic nervous system regulation, especially in cardiovascular system, the modulation of the renal nerves used as a therapeutic strategy has been researched across the world. The purpose of this study is to evaluate and quantify the morphology changes in different diseases, make the modulation therapy more selective and effective.

详细描述

People eligible for this study will be divided into 4 groups according to the eligibility criteria(Resistant Hypertension Group,Essential Hypertension Group, Chronic Heart Failure Group and Control Group), about 15 objects for each, totally 60 objects are going to be recruited.

Before the intravascular ultrasound examination, ambulatory blood pressure, ECG, plasma catecholamine hormones, renin-angiotension-aldosterone, ect. will be measured. An intravascular ultrasound examination will be taken after all of these have been done.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Resistant hypertension group
  • blood pressure remains above goal in spite of the concurrent use of three or more anti-hypertensive agents(including a diuretic) at adequate doses.
  • agrees to have the study procedure(s) performed and additional procedures and evaluations
  • Essential hypertension group
  • systolic blood pressure ≥ 140 mmHg, diastolic blood pressure ≥ 90 mmHg, or current use of anti-hypertensive medication with a normal blood pressure or mean ambulatory blood pressure during the 24-hour≥130/80 mmHg.
  • not resistant to pharmacotherapy.
  • agrees to have the study procedure(s) performed and additional procedures and evaluations
  • Chronic heart failure group
  • New York Heart Association class II-III symptoms, or American College of Cardiology(ACC) / American Heart Association(AHA) heart failure classification B-C class of chronic heart failure.
  • currently or prior have the signs of heart failure, such as elevated jugular venous pressure, peripheral edema, pulmonary crepitations, ect.
  • Systolic left ventricular dysfunction as assessed by echocardiogram with left ventricular ejection fraction < 40%.
  • agrees to have the study procedure(s) performed and additional procedures and evaluations
  • Control group
  • no history of arterial hypertension, heart failure and diabetes
  • going to take a vascular interventional examination during hospitalization
  • agrees to have the study procedure(s) performed and additional procedures and evaluations
  • All patients have full capacity for civil conduct and agree to sign the Medical Informed Consent.

排除标准

  • hemodynamically or anatomically significant renal artery stenosis.
  • renal artery variation.
  • renal artery diameter < 4 mm, trunk length < 20 mm.
  • secondary hypertension with known causes and pseudo-hypertension.
  • has experienced myocardial infarction, unstable angina pectoris, or cerebrovascular accident within 6 months.
  • has an implantable cardioverter defibrillator (ICD) or pacemaker.
  • requires respiratory support.
  • is pregnant or planning to be pregnant.
  • cardiovascular diseases with sever hemodynamic disorder.
  • type 1 diabetes mellitus.
  • currently enrolled in another investigational drug or device trial.
  • civil disability or limited capacity for civil conduct.
  • other conditions researchers considered unsuitable for enrolled in the trial.

结局指标

主要结局

Area increase of Renal nerves in patients with sympathetic over-activity diseases

时间窗: A duration of the whole research stage, an expected average of 1/2 year

Total area of the renal nerve (measured by ultrasound imaging host) of each patient: square millimeter (mm²)=∑= Nerve 1(length\*width)+ Nerve 2(length\*width)+ ......+ Nerve n(length\*width);

The increase of the ratio of nerve area/artery wall area in patients with sympathetic over-activity diseases.

时间窗: A duration of the whole research stage, an expected average of 1/2 year

1. Renal artery area of each patient (measured by ultrasound imaging host): Square millimeter (mm²); 2. Renal arterial wall area (measured by ultrasound imaging host) of each patient: Square millimeter (mm²); 3. Total area of the renal nerve/Total renal artery area: percentage (%); 4. Total area of the renal nerve/Total renal arterial wall area: percentage (%);

Number increase of Renal nerves in patients with sympathetic over-activity diseases

时间窗: A duration of the whole research stage, an expected average of 1/2 year

Total number of the renal nerve of each patient(automatic identification by the embedded software in the ultrasound imaging host/counting manually): Number of Nerve Bundles;

次要结局

  • Number of Participants with Serious and Non-Serious Adverse Events Related to The Intervention Procedure(Participants will be followed for the duration of the operation time, an expected average of 0.5-1 hours)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jing Huang

Professor and Vice Director, Department of Cardiology

The Second Affiliated Hospital of Chongqing Medical University

研究点 (1)

Loading locations...

相似试验